BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12430855)

  • 1. Immune pathophysiology of aplastic anemia.
    Maciejewski JP; Risitano A; Kook H; Zeng W; Chen G; Young NS
    Int J Hematol; 2002 Aug; 76 Suppl 1():207-14. PubMed ID: 12430855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
    Plasilova M; Risitano A; Maciejewski JP
    Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
    Maciejewski JP; O'Keefe C; Gondek L; Tiu R
    Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
    Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
    Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome.
    Wlodarski MW; Gondek LP; Nearman ZP; Plasilova M; Kalaycio M; Hsi ED; Maciejewski JP
    Blood; 2006 Oct; 108(8):2632-41. PubMed ID: 16614248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep sequencing and flow cytometric characterization of expanded effector memory CD8
    Giudice V; Feng X; Lin Z; Hu W; Zhang F; Qiao W; Ibanez MDPF; Rios O; Young NS
    Haematologica; 2018 May; 103(5):759-769. PubMed ID: 29419434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared and individual specificities of immunodominant cytotoxic T-cell clones in paroxysmal nocturnal hemoglobinuria as determined by molecular analysis.
    Plasilova M; Risitano AM; O'Keefe CL; Rodriguez A; Wlodarski M; Young NS; Maciejewski J
    Exp Hematol; 2004 Mar; 32(3):261-9. PubMed ID: 15003311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry.
    Risitano AM; Kook H; Zeng W; Chen G; Young NS; Maciejewski JP
    Blood; 2002 Jul; 100(1):178-83. PubMed ID: 12070025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of clonal cytogenetic abnormalities in aplastic anemia.
    Maciejewski JP; Selleri C
    Leuk Lymphoma; 2004 Mar; 45(3):433-40. PubMed ID: 15160903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia.
    Piao W; Grosse J; Czwalinna A; Ivanyi P; Ganser A; Franzke A
    Exp Hematol; 2005 Jul; 33(7):804-10. PubMed ID: 15963856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia.
    Wlodarski MW; O'Keefe C; Howe EC; Risitano AM; Rodriguez A; Warshawsky I; Loughran TP; Maciejewski JP
    Blood; 2005 Oct; 106(8):2769-80. PubMed ID: 15914562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a CD4+ T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia.
    Nakao S; Takamatsu H; Yachie A; Itoh T; Yamaguchi M; Ueda M; Shiobara S; Matsuda T
    Exp Hematol; 1995 May; 23(5):433-8. PubMed ID: 7720814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune mechanism of aplastic anemia.
    Nakao S
    Int J Hematol; 1997 Aug; 66(2):127-34. PubMed ID: 9277043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clonal hematopoiesis in aplastic anemia].
    Makishima H
    Rinsho Ketsueki; 2018; 59(10):1962-1968. PubMed ID: 30305498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation.
    O'keefe CL; Sobecks RM; Wlodarski M; Rodriguez A; Bell K; Kuczkowski E; Bolwell BJ; Maciejewski JP
    Exp Hematol; 2004 Oct; 32(10):1010-22. PubMed ID: 15504556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune pathophysiology of aplastic anemia.
    Nakao S; Feng X; Sugimori C
    Int J Hematol; 2005 Oct; 82(3):196-200. PubMed ID: 16207590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited heterogeneity of T cell receptor BV usage in aplastic anemia.
    Zeng W; Maciejewski JP; Chen G; Young NS
    J Clin Invest; 2001 Sep; 108(5):765-73. PubMed ID: 11544283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
    Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP
    Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.